FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health; Improvements in FDA rare disease New Drug Application review process; H.R. 5684 / S. 3304 - Medical Foods and Formulas Access Act.
2026 · 2nd Quarter (Apr 1 - June 30)
UNITED MITOCHONDRIAL DISEASE FOUNDATION
Filed by HOLLAND & KNIGHT LLP.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 17, 2026
- Income
- $20,000.00
- Expenses
- Not reported
- Registrant
- HOLLAND & KNIGHT LLP
- Filing UUID
- e2b2d1ef-b251-4d2d-81b3-f46751e209cd
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.